Paediatric Rheumatology Update

Vaccinations in Paediatric Rheumatology: an Update on Current Developments

In 2011, the European League Against Rheumatism (EULAR) published recommendations regarding the vaccination of children with rheumatic diseases. These recommendations were based on a systematic literature review published in that same year. Since then, the evidence body on this topic has grown substantially. This review provides an update of the systematic literature study of 2011, summarizing ...

Glucocorticoids in paediatric rheumatology.

Glucocorticoid (GC) drugs are the most potent anti-inflammatory agents available for the treatment of paediatric rheumatic diseases. These medications are used for the management of extra-articular features of systemic juvenile idiopathic arthritis and are the mainstay of therapy in children with juvenile systemic lupus erythematosus, juvenile dermatomyositis, and systemic vasculitis. The gener...

The Growth of Paediatric Rheumatology

I May 1995, paediatric rheumatology was officially recognized as a speciality for training by the Royal College of Physicians in the UK. Since then, there has been a great deal of activity in terms of defining the provision of service within the speciality and training of doctors to provide the service. The General Medical Council now registers it as a sub-speciality of paediatrics. It is perh...

Information technology in paediatric rheumatology.

Information technology in paediatric rheumatology has seen several exciting developments in recent years. The new multidimensional questionnaires for juvenile idiopathic arthritis, juvenile dermatomyositis, and juvenile autoinflammatory diseases integrate all major parent- and child-reported outcomes (PCROs) used in these diseases into a single tool, and provide an effective guide to manage, do...

A regional paediatric rheumatology service.